Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 90Triple Negative Breast Neoplasms 18Stomach Neoplasms 14Inflammatory Breast Neoplasms 12Esophageal Neoplasms 7Lymphoma, Large B-Cell, Diffuse 5Testicular Neoplasms 3Pancreatic Neoplasms 3Lymphoma 3Adenocarcinoma Of Esophagus 3Urinary Bladder Neoplasms 2Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Neoplasms 2Lymphoma, B-Cell, Marginal Zone 2Carcinoma, Hepatocellular 2Carcinoma, Adenoid Cystic 2Breast Neoplasms, Male 2pCR Rate 1Women With Primary Breast Cancer 1Upper Tract Urothelial Carcinoma 1Unilateral HER2 Positive Breast Cancer 1Thymoma 1Testicular Germ Cell Tumor 1Small Cell Lung Cancer Extensive Stage 1Rare Tumour 1Prostatic Neoplasms 1Primary Breast Cancer 1

Interventions

pembrolizumab 2Radiotherapy 2Etoposide 2Carboplatin 2sintilimab 1irinotecan sucrosofate 1durvalumab 1camrelizumab 1atezolizumab 1apatinib 1anlotinib 1amrubicin 1Platinum 1Paclitaxel 1NPI 2358 1Immunotherapy 1Immune Checkpoint Inhibitors 1Epirubicin 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Small Cell Lung Cancer Extensive Stage × Epirubicin × Clear all
NCT03755115 2019-01-16

SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer

Henan Cancer Hospital

Phase 2 Unknown
40 enrolled
Thoracic

Small Cell Lung Cancer Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡